doi: 10.3390/antiox14101235
[4] Conditions that match a drugs FDA approval generally qualify, whether youre using these major GLP-1 brands or similar: Ozempic/Mounjaro: type 2 diabetes [5] Wegovy/Zepbound: obesity (BMI 30) [6] Wegovy/Zepbound: overweight with at least one weight-related condition (BMI 27 to under 30 plus hypertension, high cholesterol, sleep apnea, cardiovascular disease, or type 2 diabetes) [7] Zepbound: obstructive sleep apnea [8] Wegovy: metabolic-associated steatohepatitis (MASH) [9] Off-label conditions can count too when your clinician documents a real diagnosis such as prediabetes, binge eating disorder, or PCOS
Care at Home: Support your energy levels with SkinCeuticals B-Complex supplements, which provide a sustained release of energy throughout the day
Why Choose Port City Plastic Surgery
Two key nutrients, fibre and protein, play a significant role in stimulating its production
Lilly removed this from the slide deck, but I managed to snag a picture at the presentation We can see the women in the trial were already at 30.8% weight loss at 80 weeks on the max dose with the 9mg dose only 2% behind and both still losing weight
